Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ALFUZOSIN HYDROCHLORIDE EXTENDED-RELEASE TABLET safely and effectively. See full prescribing information for ALFUZOSIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS. ALFUZOSIN hydrochloride extended-release tablets, for oral use Initial U.S. Approval: 2003
Medication labelWhy this: Advisory · dailymed-prescription
Alfuzosin hydrochloride extended-release tablets, USP are indicated for the treatment of signs and symptoms of benign prostatic hyperplasia. Alfuzosin hydrochloride extended-release tablets, USP are not indicated for the treatment of hypertension. Alfuzosin hydrochloride extended-release tablets, USP are not indicated for use in pediatric population.
- generic_name
- alfuzosin hydrochloride
- product_names
- Alfuzosin hydrochloride
- ndc
- 63629-9155, 29300-155, 63629-9155-1, 63629-9155-2, 63629-9155-3, 63629-9155-4
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en